Target Name: WDFY4
NCBI ID: G57705
Review Report on WDFY4 Target / Biomarker Content of Review Report on WDFY4 Target / Biomarker
WDFY4
Other Name(s): WD repeat- and FYVE domain-containing protein 4 | Protein WDFY4 | C10orf64 | KIAA1607 | WDFY family member 4 | truncated WD repeat- and FYVE domain-containing protein 4 | WDFY4_HUMAN | FLJ45748 | MGC40604 | WDFY4 variant 1 | FLJ36288 | MGC45899 | WD repeat- and FYVE domain-containing protein 4 (isoform 1) | FLJ17416

WDFY4: A Potential Drug Target and Biomarker

The protein WDFY4, also known as WDFY4-containing protein 4, is a protein that has been identified as a potential drug target and biomarker. WDFY4 is a 21-kDa protein that is expressed in various tissues, including muscle, heart, brain, and kidney. It is composed of two distinct domains: a N-terminal transmembrane domain and a C-terminal cytoplasmic domain.

The N-terminal transmembrane domain of WDFY4 contains a unique structural feature known as a variable region. This region is composed of a long amino acid sequence that is responsible for the protein's ability to enter the endoplasmic reticulum (ER) and for its subsequent cytoplasmic localization. The variable region of WDFY4 contains several unique amino acids that are specific to this protein and are involved in its function.

The C-terminal cytoplasmic domain of WDFY4 is responsible for the protein's ability to interact with other cellular structures and for its role in cellular signaling. This domain contains several unique amino acids that are specific to this protein and are involved in its function.

WDFY4 has been shown to play a role in several cellular processes, including the regulation of cellular signaling pathways, cell division, and protein synthesis. It has also been shown to interact with several different proteins, including the protein tyrosine kinase (TK) and the protein serine/thionine-protein kinase (STK).

Based on these findings, it is possible that WDFY4 could be a drug target. By inhibiting the activity of WDFY4, it may be possible to treat a variety of cellular processes that are affected by this protein, including the regulation of cellular signaling pathways, cell division, and protein synthesis. This could lead to the development of new treatments for a variety of diseases.

In addition to its potential as a drug target, WDFY4 has also been shown to be a potential biomarker. Its unique structure and the proteins with which it interacts suggest that it could be used as a diagnostic tool for a variety of diseases. For example, if WDFY4 is expressed abnormally in a particular tissue or at a particular level, it may be a diagnostic indicator of a variety of diseases, including neurodegenerative disorders, cancer, and cardiovascular disease.

In conclusion, WDFY4 is a protein that has the potential to be a drug target and biomarker. Its unique structure and the proteins with which it interacts suggest that it could be used to treat a variety of cellular processes and to serve as a diagnostic tool for a variety of diseases. Further research is needed to fully understand the function and potential of this protein.

Protein Name: WDFY Family Member 4

Functions: Plays a critical role in the regulation of cDC1-mediated cross-presentation of viral and tumor antigens in dendritic cells. Mechanistically, acts near the plasma membrane and interacts with endosomal membranes to promote endosomal-to-cytosol antigen trafficking. Also plays a role in B-cell survival through regulation of autophagy

The "WDFY4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDFY4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2